Showing results (81-90 of 457) with videos related to

Sort By:
Pageof 46
Lupus Science & Medicine|June 28, 2020
Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic reviewVibeke Strand, Lee S Simon, Alexa Simon Meara, et al.
Clinical and Experimental Rheumatology|July 13, 2018
Short-term costs associated with non-medical switching in autoimmune conditionsAllan Gibofsky, Martha Skup, Min Yang, et al.
RMD Open|May 14, 2016
Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritisRoy Fleischmann, Vibeke Strand, Bethanie Wilkinson, et al.
Pharmacoeconomics|January 31, 2002
Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: an evaluation based on a 1-year randomised controlled trialAndreas Maetzel, Vibeke Strand, Peter Tugwell, et al.
Arthritis and Rheumatism|January 11, 2003
Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritisAndreas Maetzel, Vibeke Strand, Peter Tugwell, et al.
Patient Related Outcome Measures|January 23, 2019
Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studiesElvira Bangert, Laura Wakani, Mehveen Merchant, et al.
The Journal of Rheumatology|May 8, 2003
OMERACT workshop: repair of structural damage in rheumatoid arthritisDésirée Van Der Heijde, John T Sharp, Rolf Rau, et al.
Plos One|May 14, 2013
Impact of rheumatoid arthritis disease activity test on clinical practiceJohn W Peabody, Vibeke Strand, Riti Shimkhada, et al.
Postgraduate Medicine|October 12, 2013
Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 studyAllan Gibofsky, Stephen Silberstein, Charles Argoff, et al.
Expert Review of Clinical Immunology|May 19, 2010
Outcome measures in rheumatoid arthritis: the OMERACT processPeter Brooks, Maarten Boers, Lee S Simon, et al.
Pageof 46